Abstract
Background
Ventilatory parameters obtained during exercise predict survival in several chronic diseases; however, long-term changes in exercise ventilatory parameters in patients with cystic fibrosis (CF) have yet to be examined and potential differences between sexes in CF are unknown.
Purpose
We sought to examine the change in exercise ventilatory parameters over time in patients with CF and determine if the change is different between sexes.
Methods
Exercise capacity (VO2 peak) and exercise ventilatory parameters (VE/VO2 peak, VE/VCO2 peak, and VE/VCO2 slope) were determined from a maximal cardio-pulmonary test on a cycle ergometer on two visits separated by 39 ± 16 months in 20 patients with CF (10 female, 10 male).
Results
No differences between sexes were observed at visit 1 (all p > 0.05). Overall, exercise ventilatory parameters significantly (p < 0.05) deteriorated between visits, with no change (p > 0.05) in VO2 peak. Moreover, compared to males, female patients exhibited greater deteriorations in VE/VO2 peak (p = 0.001), VE/VCO2 peak (p = 0.002), and VE/VCO2 slope (p = 0.016) between visits.
Conclusions
These data in patients with CF indicate that exercise ventilatory parameters decline over time despite no change in VO2 peak, and female patients exhibit a more rapid deterioration compared to males.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CF:
-
Cystic fibrosis
- CPET:
-
Cardio-pulmonary exercise test
- DXA:
-
Dual-energy X-ray absorptiometry
- FeCO2 :
-
Fraction of expired CO2
- FEV1 :
-
Forced expiratory volume in 1 s
- FFM:
-
Fat-free mass
- FVC:
-
Forced vital capacity
- MVV:
-
Maximum voluntary ventilation
- PaCO2 :
-
Partial pressure of arterial CO2
- RR:
-
Respiratory rate
- VCO2 :
-
Volume of carbon dioxide output
- V D/V T :
-
Dead space-to-tidal volume ratio
- V E :
-
Minute ventilation
- VO2 :
-
Volume of oxygen consumption
- V T :
-
Tidal volume
- VT:
-
Ventilatory threshold
References
American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152(3):1107–1136
Beaver WL, Wasserman K, Whipp BJ (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60(6):2020–2027
Cantin A (1995) Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 151(4):939–941
Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Earlbaum Associates 2, Hilsdale.
Corey M, Levison H, Crozier D (1976) Five-to seven-year course of pulmonary function in cystic fibrosis 1–3. Am Rev Respir Dis 114(6):1085–1092
Dodge J, Lewis P, Stanton M, Wilsher J (2007) Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 29(3):522–526
Fielding J, Brantley L, Seigler N, McKie KT, Davison GW, Harris RA (2015) Oxygen uptake kinetics and exercise capacity in children with cystic fibrosis. Pediatr Pulmonol 50(7):647–654
FitzSimmons SC (1993) The changing epidemiology of cystic fibrosis. J Pediatr 122(1):1–9
Godfrey S, Davies C, Wozniak E, Barnes CA (1971) Cardio-respiratory response to exercise in normal children. Clin Sci 40(5):419–431
Gratas-Delamarche A, Mercier J, Ramonatxo M, Dassonville J, Prefaut C (1993) Ventilatory response of prepubertal boys and adults to carbon dioxide at rest and during exercise. Eur J Appl Physiol Occup Physiol 66(1):25–30
Gruet M, Troosters T, Verges S (2017) Peripheral muscle abnormalities in cystic fibrosis: etiology, clinical implications and response to therapeutic interventions. J Cystic Fibros 15(5):538–552
Guazzi M, De Vita S, Cardano P, Barlera S, Guazzi MD (2003) Normalization for peak oxygen uptake increases the prognostic power of the ventilatory response to exercise in patients with chronic heart failure. Am Heart J 146(3):542–548
Hankinson J, Odencrantz J, Fedan K (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187
Hart N, Polkey MI, Clément A, Boulé M, Moxham J, Lofaso F, Fauroux B (2002) Changes in pulmonary mechanics with increasing disease severity in children and young adults with cystic fibrosis. Am J Respir Crit Care Med 166(1):61–66
Hebestreit H, Kieser S, Rüdiger S, Schenk T, Junge S, Hebestreit A, Ballmann M, Posselt H-G, Kriemler S (2006) Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Respir J 28(4):734–739
Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A (2015) Statement on exercise testing in cystic fibrosis. Respiration 90(4):332–351
Kleber F, Vietzke G, Wernecke K, Bauer U, Opitz C, Wensel R, Sperfeld A, Gläser S (2000) Impairment of ventilatory efficiency in heart failure. Circulation 101(24):2803–2809
Lands LC, Heigenhauser GJ, Jones NL (1992) Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Sci 83(4):391–397
MacGowan GA, Murali S (2000) Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak exercise oxygen consumption. Circulation 102(24):e182–e182
MacKenzie T, Gifford AH, Sabadosa KA, Quinton HB, Knapp EA, Goss CH, Marshall BC (2014) Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Intern Med 161(4):233–241
McKone EF, Barry SC, FitzGerald MX, Gallagher CG (2005) Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis. J Appl Physiol 99(3):1012–1018
Moorcroft AJ, Dodd ME, Webb AK (1997) Long-term change in exercise capacity, body mass, and pulmonary function in adults with cystic fibrosis. Chest 111(2):338–343
Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF (1992) The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 327(25):1785–1788
Orenstein DM, Nixon PA (1991) Exercise performance and breathing patterns in cystic fibrosis: male–female differences and influence of resting pulmonary function. Pediatr Pulmonol 10(2):101–105
Penketh A, Wise A, Mearns M, Hodson M, Batten J (1987) Cystic fibrosis in adolescents and adults. Thorax 42(7):526–532
Philpott J, Houghton K, Luke A (2010) Physical activity recommendations for children with specific chronic health conditions: Juvenile idiopathic arthritis, hemophilia, asthma and cystic fibrosis. Paediatr Child Health 15(4):213–218
Pianosi P, Hochman J (1996) End-tidal estimates of arterial PCO2 for cardiac output measurement by CO2 rebreathing: a study in patients with cystic fibrosis and healthy controls. Pediatr Pulmonol 22(3):154–160
Pianosi P, Wolstein R (1996) Carbon dioxide chemosensitivity and exercise ventilation in healthy children and in children with cystic fibrosis. Pediatr Res 40(3):508
Pianosi P, Leblanc J, Almudevar A (2005) Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 60(1):50–54
Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J (2012) Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 40(6):1324–1343
Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B (1997) Gender gap in cystic fibrosis mortality. Am J Epidemiol 145(9):794–803
Schneiderman-Walker J, Wilkes D, Strug L, Lands L, Pollock S, Selvadurai H, Hay J, Coates A, Corey M (2005) Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr 147(3):321–326
Schwaiblmair M, Faul C, von Scheidt W, Berghaus TM (2012) Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension. BMC Pulmon Med 12(1):23
Stein R, Selvadurai H, Coates A, Wilkes DL, Schneiderman-Walker J, Corey M (2003) Determination of maximal voluntary ventilation in children with cystic fibrosis. Pediatr Pulmonol 35(6):467–471
Takken T, Bongers BC, van Brussel M, Haapala EA, Hulzebos EH (2017) Cardiopulmonary exercise testing in pediatrics. Ann Am Thorac Soc 14(Supp 1):S123–S128
Thin A, Dodd J, Gallagher C, Fitzgerald M, Mcloughlin P (2004) Effect of respiratory rate on airway deadspace ventilation during exercise in cystic fibrosis. Respir Med 98(11):1063–1070
Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, Gosselink R, Decramer M, Dupont L (2009) Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 33(1):99–106
Tucker MA, Crandall R, Seigler N, Rodriguez-Miguelez P, McKie KT, Forseen C, Thomas J, Harris RA (2017) A single bout of maximal exercise improves lung function in patients with cystic fibrosis. J Cyst Fibros 16(6):752–758
Wasserman K, Hansen J, Sue D, Stringer W, Whipp B (2005) Clinical exercise testing. Principles of exercise testing and interpretation including pathophysiology and clinical applications. Lippincott Williams & Wilkins
Funding
Supported in part by a Vertex Pharmaceuticals Incorporated IIS Grant and NIH/NIDDK R21DK100783 (R.A.H.).
Author information
Authors and Affiliations
Contributions
MAT and RAH conceived the study; MAT, NS, PRM, JL, RHC, CF, and KTM recruited patients and collected data; MAT and RAH analyzed and interpreted data and drafted the manuscript. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Additional information
Communicated by Susan Hopkins.
Rights and permissions
About this article
Cite this article
Tucker, M.A., Lee, N., Rodriguez-Miguelez, P. et al. Exercise testing in patients with cystic fibrosis—importance of ventilatory parameters. Eur J Appl Physiol 119, 227–234 (2019). https://doi.org/10.1007/s00421-018-4018-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-018-4018-5